? Analytical, Metabolic, Instrumentation (AMI) Central Core and Proteomics Subcore The AMI Core resulted from reorganization and restructuring of two of the previous cores of the Research Center for Liver Diseases (RCLD) in 2007. The newly established Core pooled the existing shared instrumentation base and the analytical resources-services, both of which have grown continuously and substantially since. In addition, the Core established a Proteomics Subcore, which at its inception was a laboratory-based entity, with Center Members being its exclusive user base it was called to serve. Subsequently, RCLD's leadership led to a strong commitment from USC School of Medicine and the Provost's office, securing capital funding for new, state-of-the-art instrumentation and space renovation. Thus, the Subcore has grown since to become a university-wide Proteomics Core. However, the Core, located a floor below the Central Core, continues providing priority access/service to Center Members as a Subcore. The following are the goals of the Central Core and Proteomics Subcore. Central Core:
The aims of the Central Core are to provide the following resources and services: 1) An extensive (currently 26) base of well maintained and critically needed common as well as advanced, state-of-the-art equipment for shared access-use. 2) A versatile and powerful HPLC system equipped with photodiode array, fluorescence, electrochemical and radioactivity detectors, offering a menu of 15 analytical and preparative separations. 3) A newly installed computer workstation for modeling-simulation applications with a growing set of software tools, currently supporting DILIsym, MITOsym, SimPop and MATLAB packages. 4) Assisting-advising investigators and their personnel in evaluation, selection and optimal utilization of the Core's base of resources and services. 5) Training-orientation of a constantly evolving base of users in hands- on operation of the core's resources and services. Proteomics Subcore:
The aims of the Subcore are to provides state-of-the-art mass spectrometry-based proteomics services on a priority basis to Center Members, including: 1) Protein sequencing and identification from gel bands and complex mixture of proteins in solutions. 2) Analysis and determination of post-translational modification in proteins. 3) Quantitative and qualitative proteomic profiling. 4) Advising/assisting with experimental strategies-designs related to protein purification and proteomics projects.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK048522-25
Application #
9883016
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
Budget Start
2020-03-01
Budget End
2021-02-28
Support Year
25
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Southern California
Department
Type
DUNS #
072933393
City
Los Angeles
State
CA
Country
United States
Zip Code
90089
Nakamura, Brooke N; Glazier, Alison; Kattah, Michael G et al. (2018) A20 regulates canonical wnt-signaling through an interaction with RIPK4. PLoS One 13:e0195893
Guo, Hao; Lee, Changrim; Shah, Mihir et al. (2018) A novel elastin-like polypeptide drug carrier for cyclosporine A improves tear flow in a mouse model of Sjögren's syndrome. J Control Release 292:183-195
Wu, Raymond; Murali, Ramachandran; Kabe, Yasuaki et al. (2018) Baicalein Targets GTPase-Mediated Autophagy to Eliminate Liver Tumor-Initiating Stem Cell-Like Cells Resistant to mTORC1 Inhibition. Hepatology 68:1726-1740
Ogasawara, Noriko; Poposki, Julie A; Klingler, Aiko I et al. (2018) IL-10, TGF-?, and glucocorticoid prevent the production of type 2 cytokines in human group 2 innate lymphoid cells. J Allergy Clin Immunol 141:1147-1151.e8
Edman, Maria C; Janga, Srikanth R; Meng, Zhen et al. (2018) Increased Cathepsin S activity associated with decreased protease inhibitory capacity contributes to altered tear proteins in Sjögren's Syndrome patients. Sci Rep 8:11044
Baulies, Anna; Montero, Joan; Matías, Nuria et al. (2018) The 2-oxoglutarate carrier promotes liver cancer by sustaining mitochondrial GSH despite cholesterol loading. Redox Biol 14:164-177
Ju, Yaping; Janga, Srikanth Reddy; Klinngam, Wannita et al. (2018) NOD and NOR mice exhibit comparable development of lacrimal gland secretory dysfunction but NOD mice have more severe autoimmune dacryoadenitis. Exp Eye Res 176:243-251
Peddi, Santosh; Pan, Xiaoli; MacKay, John Andrew (2018) Intracellular Delivery of Rapamycin From FKBP Elastin-Like Polypeptides Is Consistent With Macropinocytosis. Front Pharmacol 9:1184
Zhou, Beiyun; Flodby, Per; Luo, Jiao et al. (2018) Claudin-18-mediated YAP activity regulates lung stem and progenitor cell homeostasis and tumorigenesis. J Clin Invest 128:970-984
Khanova, Elena; Wu, Raymond; Wang, Wen et al. (2018) Pyroptosis by caspase11/4-gasdermin-D pathway in alcoholic hepatitis in mice and patients. Hepatology 67:1737-1753

Showing the most recent 10 out of 449 publications